BREAST CANCER

Adverse reaction reported in 66,293 FDA reports across 11 drugs.

66,293
Total Reports
11
Drugs Involved
Ranitidine
Most Reported Drug

Drugs Associated with BREAST CANCER

Drugs where "BREAST CANCER" was reported as an adverse event.

# Drug Reports % of Total
1 Ranitidine 24,854
37.5%
2 Estrogens, Conjugated 9,642
14.5%
3 Conjugated Estrogens 9,623
14.5%
4 Medroxyprogesterone 8,168
12.3%
5 Conjugated Estrogens / Medroxyprogesterone Acetate 7,888
11.9%
6 Estradiol 1,880
2.8%
7 Letrozole 1,823
2.7%
8 Anastrozole 1,038
1.6%
9 Exemestane 777
1.2%
10 Lapatinib 300
0.5%
11 Raloxifene 300
0.5%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. The presence of a drug in this list does not mean the drug caused breast cancer. Always consult your healthcare provider.